Cuscó I - Search Results

1

A Novel Intragenic Duplication in the HDAC8 Gene Underlying a Case of Cornelia de Lange Syndrome.

Lucia-Campos C, Valenzuela I, Latorre-Pellicer A, Ros-Pardo D, Gil-Salvador M, Arnedo M, Puisac B, Castells N, Plaja A, Tenes A, Cuscó I, Trujillano L, Ramos FJ, Tizzano EF, Gómez-Puertas P, Pié J. Lucia-Campos C, et al. Among authors: cusco i. Genes (Basel). 2022 Aug 8;13(8):1413. doi: 10.3390/genes13081413. Genes (Basel). 2022. PMID: 36011323 Free PMC article.

2

Characterisation of SMN hybrid genes in Spanish SMA patients: de novo, homozygous and compound heterozygous cases.

Cuscó I, Barceló MJ, del Rio E, Martín Y, Hernández-Chico C, Bussaglia E, Baiget M, Tizzano EF. Cuscó I, et al. Hum Genet. 2001 Mar;108(3):222-9. doi: 10.1007/s004390000452. Hum Genet. 2001. PMID: 11354634

3

Should gamete donors be tested for spinal muscular atrophy?

Tizzano EF, Cuscó I, Barceló MJ, Parra J, Baiget M. Tizzano EF, et al. Among authors: cusco i. Fertil Steril. 2002 Feb;77(2):409-11. doi: 10.1016/s0015-0282(01)02994-6. Fertil Steril. 2002. PMID: 11821106 Free article.

4

Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients.

Gamez J, Barceló MJ, Muñoz X, Carmona F, Cuscó I, Baiget M, Cervera C, Tizzano EF. Gamez J, et al. Among authors: cusco i. Neurology. 2002 Nov 12;59(9):1456-60. doi: 10.1212/01.wnl.0000032496.64510.4e. Neurology. 2002. PMID: 12427907

5

Implementation of SMA carrier testing in genetic laboratories: comparison of two methods for quantifying the SMN1 gene.

Cuscó I, Barceló MJ, Baiget M, Tizzano EF. Cuscó I, et al. Hum Mutat. 2002 Dec;20(6):452-9. doi: 10.1002/humu.10144. Hum Mutat. 2002. PMID: 12442269

6

Prenatal diagnosis for risk of spinal muscular atrophy.

Cuscó I, Barceló MJ, Soler C, Parra J, Baiget M, Tizzano E. Cuscó I, et al. BJOG. 2002 Nov;109(11):1244-9. BJOG. 2002. PMID: 12452462

7

A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.

Cuscó I, López E, Soler-Botija C, Jesús Barceló M, Baiget M, Tizzano EF. Cuscó I, et al. Hum Mutat. 2003 Aug;22(2):136-43. doi: 10.1002/humu.10245. Hum Mutat. 2003. PMID: 12872254

8

Detection of novel mutations in the SMN Tudor domain in type I SMA patients.

Cuscó I, Barceló MJ, del Río E, Baiget M, Tizzano EF. Cuscó I, et al. Neurology. 2004 Jul 13;63(1):146-9. doi: 10.1212/01.wnl.0000132634.48815.13. Neurology. 2004. PMID: 15249625

9

Choline acetyltransferase expression does not identify early pathogenic events in fetal SMA spinal cord.

Soler-Botija C, Cuscó I, López E, Clua A, Gich I, Baiget M, Ferrer I, Tizzano EF. Soler-Botija C, et al. Among authors: cusco i. Neuromuscul Disord. 2005 Mar;15(3):253-8. doi: 10.1016/j.nmd.2004.11.006. Epub 2005 Jan 28. Neuromuscul Disord. 2005. PMID: 15725587

10

Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function?

Soler-Botija C, Cuscó I, Caselles L, López E, Baiget M, Tizzano EF. Soler-Botija C, et al. Among authors: cusco i. J Neuropathol Exp Neurol. 2005 Mar;64(3):215-23. doi: 10.1093/jnen/64.3.215. J Neuropathol Exp Neurol. 2005. PMID: 15804053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page